This article originally appeared on the Motley Fool. <\/p>\n
The science of deep learning, a sub-discipline ofartificial intelligence(AI), is only a recent development in the grand scheme of things, but during its short existence, it has been producing some impressive technological achievements. Advances in image recognition, language understandingand translation have led to the development ofvirtual assistants,smart home speakersandgainsincybersecurity, and they are leading the charge towardautonomous driving. Now, companies have found a way to use those AI smarts to fight cancer. <\/p>\n
Deep learninginvolves the construction of artificial neural networks, using software and complex algorithms to recreate the capacity of the human brain to learn. These learning computers have a particular knack for sifting through vast amounts of data and recognizing patterns, getting smarter as they go. The first breakthrough involved feeding a system thousands of pictures of cats until the program was able to recognize a cat on its own. <\/p>\n
This ability to identify patterns has led to a significant breakthrough in the area of breast cancer research. Last month, in a paper titledDetecting Cancer Metastases on Gigapixel Pathology Images,Google announced that it had created a neural network that could analyze medical images and identify tumors with a greater degree of accuracy than human pathologists. The study revealed that the company, using itsGoogLeNet AI, reviewed thousands of medical images supplied by a Dutch university and was able to identify malignant tumors in breast cancer images with an 89 percentaccuracy rate, compared to 73 percentfor its human counterparts. In ablog, Google researchers explained: <\/p>\n
Pathologists are responsible for reviewing all the biological tissues visible on a slide. However, there can be many slides per patient, each of which is 10+ gigapixels when digitized at 40X magnification. Imagine having to go through a thousand 10 megapixel (MP) photos, and having to be responsible for every pixel. Needless to say, this is a lot of data to cover, and often time is limited. <\/p>\n
Cancer cells are seen on a large screen connected to a microscope at the CeBit computer fair in Hanover, Germany, March, 6, 2012. Reuters <\/p>\n
This technology has the potential to provide initial screenings, allowing doctors to review only those images that have been flagged as potentially cancerous. The system still requires improvement, as it generated a number of false positivesidentifying cancerous cells where none were present. So, while AI won't be replacing pathologists anytime soon, these algorithms could be used to pre-screen images and not only reduce the workload on doctors, but also serve parts of the world where pathologists are in short supply. <\/p>\n
Google isn't the only one testing AI for this purpose. Nearly a year ago, International Business Machines Corporationpartnered with numerous health systems, imaging technology companies, and academic medical centers to trainWatson AI, its cognitive computer, to read medical images. This more broadly based collaboration is focusing on cancer, cardiovascular disease, eye healthand diabetes. The company announced last month that it had expanded that initiative to 24 organizations worldwide, which will provide the vital input necessary to train the system. IBM also announced the first fruits of this endeavor, an application for the detection of one type of cardiovascular disease involving a narrowing of the heart's aortic valve. It plans to expand Watson's efforts to a variety of additional cardiovascular conditions in the near future. <\/p>\n
Watson is already seeing success in a number ofmedical applications. In its most impressive results in the field to date, Watsonreviewedthe medical records of 1,000 cancer patients and was able to develop a treatment plan that concurred with oncologists' recommendations with 99 percentaccuracy. The AI was also able to provide additional recommendations in about 30 percentof cases that had been missed by doctors, thanks to its ability to review eventhe most recent medical research. <\/p>\n
Neither company provides specific information regarding how these AI-related medical breakthroughs would contribute to the overall business, and any contribution would represent only a minuscule part of each company's total revenue at this juncture. These are still extremely early developments, but they illustrate the vast potential of AI in the not-too-distant future. <\/p>\n
<\/p>\n
Read the original post:<\/p>\n
Artificial Intelligence's Potential to Transform Medical Screening - Newsweek<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" This article originally appeared on the Motley Fool. The science of deep learning, a sub-discipline ofartificial intelligence(AI), is only a recent development in the grand scheme of things, but during its short existence, it has been producing some impressive technological achievements. Advances in image recognition, language understandingand translation have led to the development ofvirtual assistants,smart home speakersandgainsincybersecurity, and they are leading the charge towardautonomous driving Continue reading